Avita Therapeutics Inc (NASDAQ:RCEL)

20.56
Delayed Data
As of Oct 30
 -1.44 / -6.55%
Today’s Change
20.00
Today|||52-Week Range
55.35
-54.81%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$464.0M

Company Description

AVITA Therapeutics, Inc., through its subsidiaries, engages in the development and and commercialization of medical devices used in regenerative medicine. The company is headquartered in Valencia, CA.

Contact Information

AVITA Therapeutics, Inc.
28159 Avenue Stanford
Valencia California 91355
P:(833) 462-8482
Investor Relations:

Employees

Shareholders

Other institutional5.03%
Individual stakeholders2.16%
Mutual fund holders1.71%

Top Executives

Michael S. PerryChief Executive Officer & Executive Director
David John McIntyreChief Financial Officer
Andrew QuickChief Technology Officer
Erin LibertoChief Commercial Officer
Donna ShiromaGeneral Counsel